Investor Ideas #Potcasts
529, #Cannabis News and #Stocks on the Move; (TSXV: $KHRN.V) (OTCQX: $KHRNF) (NASDAQ:
$TLRY) (OTC: $ZAAG)
(CSE: $CRFT.C) (TSXV: $NDVA.V)
Delta, Kelowna, BC, February 10, 2020 (Investorideas.com
Newswire) www.Investorideas.com, a global news source covering leading sectors
including marijuana and hemp stocks and its potcast site,
www.potcasts.ca release today’s podcast edition of cannabis news and stocks to watch plus insight
from thought leaders and experts.
Listen to the podcast:
https://www.investorideas.com/Audio/Podcasts/2021/021021-StocksToWatch.mp3
Read this in full
at https://www.investorideas.com/news/2021/cannabis-potcasts/02101KHRN-TLRY-ZAAG-CRFT-NDVA.asp
Hear the investor ideas potcast on Spotify
Hear Investor ideas cannabis potcast on iTunes
Today’s podcast overview/transcript:
Good
afternoon and welcome to another episode of Investorideas.com
"Potcast" featuring cannabis news, stocks to watch as well as
insights from thought leaders and experts.
In
today’s podcast we will be looking at a few public and private company
announcements.
Khiron
Life Sciences Corp. (TSXV: KHRN) (OTCQX: KHRNF), a vertically integrated
cannabis leader with core operations in Latin America and Europe, today announced that it will launch two
additional small-format Zerenia™ clinics in Q1 2021. The new clinics, which
follow on the successful launch of the Company's first small-format clinic in
Medellin, will be located in high-traffic, medical-hub neighbourhoods in two of
Colombia's largest metropolitan centres outside of Bogota.
The two new small-format Zerenia™
clinics, which are expected to open in early March, will expand Khiron's
network to six clinics, improving regional access to the Company's clinic
services and medical cannabis products for patients across the country.
"Since opening our first
small-format Zerenia™ clinic in Medellin in December 2020, we have seen
tremendous patient demand for our products and services. Patient consultations
and prescriptions continue to accelerate, with eight of every ten patients now
receiving a paid prescription, despite operating in pandemic conditions. Having
proven the demand for local physicians and the robust economics associated with
small-format clinics, Khiron will continue to expand its regional presence, in
Colombia and beyond," comments Alvaro Torres, Khiron CEO and Director.
Supported by Khiron's larger clinics
licences, the two new Zerenia™ small-format clinics will provide consultations
both in person and through the Doctor Zerenia™ telemedicine platform,
connecting patients with medical specialists trained in the ethical, safe, and
responsible prescription of cannabis-based medications. Medical cannabis continues to be validated as
an effective treatment of pathologies such as chronic pain, anxiety, insomnia,
depression, headache, epilepsy, and Parkinson's Disease.
Econic
Crop Solutions Inc, a Division of ZA Group Inc. (OTC: ZAAG) announced that it has commenced the
manufacturing and assembly of the next 10 medical cannabis grow pods. Once
completed, these pods will be strategically placed within the first three First
Nations communities where the company's previously reported grow operations are
already underway. The company-owned pod manufacturing plant is located at 7607
Edgar Industrial Drive in Red Deer, Alberta. Plant manager, Brian Cruickshank,
reported that the next 10 pods are being completed sequentially with the first
ones ready for deployment in early March with all 10 ready for deployment by
the end of March. He further stated that the manufacturing plant is able to
produce these pods at a rate of 10 per month on an ongoing basis.
As previously reported, harvesting
has been underway since late January on the three pilot demonstration pods for
three separate First Nations communities. The results appear to be on target
with anticipated revenues of $100,000 per pod within a three month growing
season. The deployment of the 10 newly assembled pods starting in early March
and continuing onward illustrates exponential growth potential even within the
first year of the company's operations. At the same time, the orderly and
incremental rollout of grow pod facilities allows the company to fine tune the
grow facilities as it expands.
When asked to provide his comments,
Wade Eno, CEO of Econic stated, "The excitement amongst our First Nations
business colleagues to see these grow pods come into their communities is
tremendous. Our manufacturing plant could not keep up with the volume demand we
are experiencing. The three communities for which we are completing the first
harvest have all requested 100 pods each and new requests from other First
Nations communities are being processed weekly. We believe the rollout of 10
pods per month will give us the ability to respond quickly to any challenges
along the way while we look forward to revenues of $1,000,000 per quarter from
each group of 10 pods."
John Morgan, President of ZA Group,
stated, "I support the strategy reflected in the comments by Mr. Eno. The
medical cannabis industry has seen exponential growth in the past several years
and the potential in this industry remains very high. The companies
experiencing the best success are those which start small and then expand in a
controlled fashion from the revenues accrued. Econics has assembled the team to
build and operate the grow pods, and it has a demonstrated network of
enthusiastic First Nations community partners that confirms unlimited expansion
potential."
BC
Craft Supply Co. Ltd. (CSE:CRFT) announced a new product into its supply chain
from renowned BC micro cultivator, Dunn
Cannabis Inc.. 24kg of Screwhead has
been purchased by BC Craft and shipped to Indiva
Limited (TSXV:NDVA) (OTCQX:NDVAF) for processing into Indiva’s new
premium brand, Artisan Batch. The
crystal covered buds are processed into sleek 3.5 gram jars which are now
available in BC through private and provincial retailers. Artisan Batch features strains from BC
Craft’s small scale and micro cultivators across Canada and is quickly becoming
a top craft brand in today’s recreational market.
Dunn Cannabis is based out of
Abbotsford, British Columbia and is run by a legacy production team of 3 with
over 42 years of cannabis experience. “We’re one of the first micros in BC and
we’re fresh out of the gate with a new business that is very unique within the
existing market,” says Robert Logan Dunn, owner of Dunn Cannabis. “We’re unique
in that we’re production-attentive, focussed on what experienced consumers
expect and provide new consumers a product they will feel confident in.
Bringing this clarity as a legacy producer is a great opportunity to show how
this can work. Dunn Cannabis is
different, we sacrifice larger yielding cultivars with genetics that we know
are going to dazzle the consumer.” Dunn and his team have refined their
cultivation methods for decades to create high-grade, small-batch cannabis that
the recreational market has been burning for.
Artisan Batch products have had
tremendous success with many provincial distributors selling out within 24
hours, supply has been difficult to keep on the shelf. It is hard to miss the
high praise and accolades from cannabis reviewers and cannabis consumers on
social media platforms. This feedback solidifies the BC Craft business model of
bringing legacy small-scale cultivators to thrive in today’s regulated market.
Matthew Watters, CEO of BC Craft
further stated, “Dunn Cannabis continues to delight consumers in the
recreational market with their high quality, artisanal flower. We are excited
to bring another new cultivar to market, and thus far the consumer feedback has
been extremely positive.”
The Company also announces that it
has issued 72,000 incentive stock options to an officer of the Company at a
price of $0.135 per common share for a period of five years, pursuant to its
Stock Option Plan.
Tilray
Inc.
(NASDAQ: TLRY), a global pioneer in cannabis
research, cultivation, production, and distribution, announced yesterday that it has established an
agreement with Grow Pharma to import
and distribute Tilray’s medical cannabis products into the United Kingdom (UK).
This agreement allows Tilray to provide authorized UK patients in need with a
locally maintained supply of medical cannabis solutions.
Tilray expects to have a range of
GMP-certified, medical cannabis products available for patients in the UK by
March 2021. Patients looking to use medical cannabis will have access to Tilray
products in the UK by obtaining prescriptions through private practice or the
National Health Service (NHS).
Brendan Kennedy, Tilray’s Chief
Executive Officer, said, "This partnership with Grow Pharma provides
patients in need access to a sustained supply of GMP-certified, high-quality
medical cannabis and is an important step in improving access in the UK. Tilray
will continue to advocate for reasonable patient access to medical cannabis in
Europe and countries around the world."
Sascha Mielcarek, Managing Director
of Tilray Europe, said, "As demand continues to ramp up in the UK, Tilray
is well-positioned to be a leading supplier of medical cannabis products.
Regulations are progressing as more and more countries across Europe are
recognizing the benefits of medical cannabis and its potential to improve
patients’ quality of life. We’re pleased to reaffirm our commitment to
delivering medical cannabis to patients in the UK and look forward to offering
a variety of GMP-certified, pharmaceutical-grade products in the coming
months."
Pierre van Weperen, Chief Executive
Officer of Grow Pharma, said, "We’re proud to join forces with Tilray and
provide patients in need with a secure and sustainable supply of the
highest-quality medical cannabis products in the UK."
Investor ideas reminds all
listeners to read our disclaimers and disclosures on the Investorideas.com
website and that this podcast is not an endorsement to buy products or services
or securities. Investors are reminded all investment involves risk and possible
loss of investment.
Learn more about
our cannabis podcasts at https://www.investorideas.com/Audio/Potcasts.asp
Or www.potcasts.ca
Investors can trade these stocks and other ideas on our site using our list of top stock trading
apps including Robinhood , Acorn, Stash and others.
To hear more
Investorideas.com podcasts visit: https://www.investorideas.com/Audio/.
Investorideas.com
podcasts are also available on iTunes,
Spotify, Google Play Music, Stitcher, Spreaker, YouTube via Spreaker, iHeartradio and Tunein.
Potcasts is now a certified
word mark Trademark on the blockchain through Cognate, Inc. CM
Certification-Registration Number: 10468217708
About Investorideas.com - News that
Inspires Big Investing Ideas
Investorideas.com
is a recognized news source publishing third party news, research and original
financial content. Learn about investing in stocks and sector trends with our
news alerts, articles, podcasts
and videos, looking at cannabis, crypto, AI and IoT, mining, sports biotech,
water, renewable energy and more. Investor Idea’s original branded content
includes the following podcasts and columns : Crypto
Corner , Play by Play sports and stock news column, Investor
Ideas Potcasts Cannabis News and Stocks on the Move podcast and
column, Cleantech and Climate Change , Exploring Mining the AI Eye .
Disclaimer/Disclosure: Investorideas.com is a digital publisher of third party sourced news,
articles and equity research as well as creates original content, including
video, interviews and articles. Original content created by investorideas is
protected by copyright laws other than syndication rights. Our site does not
make recommendations for purchases or sale of stocks, services or products.
Nothing on our sites should be construed as an offer or solicitation to buy or
sell products or securities. All investing involves risk and possible losses.
This site is currently compensated for news publication and distribution,
social media and marketing, content creation and more. Disclosure is posted for
each compensated news release, content published /created if required but
otherwise the news was not compensated for and was published for the sole
interest of our readers and followers. Contact management and IR of each
company directly regarding specific questions. More disclaimer info: https://www.investorideas.com/About/Disclaimer.asp Learn more about publishing your news release and our
other news services on the Investorideas.com newswire https://www.investorideas.com/News-Upload/ and tickertagstocknews.com Global investors must adhere to
regulations of each country. Please read Investorideas.com privacy
policy: https://www.investorideas.com/About/Private_Policy.asp
Investor Ideas does not condone the use of
cannabis except where permissible by law. Our site does not possess,
distribute, or sell cannabis products.
Learn more about sponsoring this podcast or be a guest
and our other branded content opportunities at Investorideas.com
Follow us on Twitter https://twitter.com/Investorideas
Follow
us on Facebook https://www.facebook.com/Investorideas
Follow
us on YouTube https://www.youtube.com/c/Investorideas
Download
our Mobile App for
iPhone and Android
Join
our Investor Club https://www.investorideas.com/membership/
Contact Investorideas.com
800
665 0411
Get more
Cannabis Stock Investor
Ideas – news, articles,
podcasts and stock
directory
